Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04119336
Title Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Andrew Yee, MD
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Mass General/North Shore Cancer Center Danvers Massachusetts 01923 United States Details
*Shaded cells indicate that there was no data available from for the field